US Patent Issued to Cedars-Sinai Medical Center on July 28 for "Methods and systems for assessing inflammatory disease with deep learning" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,694,947, issued on July 28, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Methods and systems for assessing inflammatory disease with deep learning" was invented by Dermot P. McGovern (Los Angeles) and Dalin Li (Walnut, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and systems of identifying an inflammatory disease or condition, e.g., an inflammatory bowel disease in a subject using a DeepLearning model. The DeepLearning model may be used to predict, treat, monitor, and/or prevent the inflammatory disease or condition in the subject, as well as to characterize a subtype of the inflammatory di...